PHYTOCANABIDIOIDS AS AN ADDITIVE TO THE TREATMENT OF ALGIC PROCESSES: A SYSTEMATIC REVIEW

Authors

  • Maria Helena Vieira Pereira Marques Centro Universitário de Patos
  • Yan Carlos Gomes de Alencar Centro Universitário de Patos
  • Déborah Alcântara Balduíno da Nóbrega Centro Universitário de Patos
  • Fernando Wanderley Xavier Centro Universitário de Patos
  • Lara Virgínia Lira Nogueira Centro Universitário de Patos
  • Milena Nunes Alves de Sousa Centro Universitário de Patos (UNIFIP) e Faculdade São Francisco da Paraíba (FASP) http://orcid.org/0000-0001-8327-9147

DOI:

https://doi.org/10.18378/rbfh.v11i1.9546

Keywords:

Cannabis; Cannabidiol; Chronic pain; Neuropathic pain.

Abstract

Introduction: Many current therapeutic strategies are ineffective due to incomplete understanding of the mechanisms involved in chronic and neuropathic pain conditions, with this, studies suggest that Cannabis is being used in the treatment of these pains. Objective: To analyze, through a systematic review, whether in patients with chronic or neuropathic pain, the use of cannabis associated with conventional treatment, when compared to treatment alone, helps to minimize pain. Methodology: This is a Systematic Review of Intervention based on the use of Randomized Clinical Trials. The studies were evaluated using several research methods and searches in electronic databases: Virtual Health Library (VHL), Scientific Electronic Library Online (SciELo), National Library of Medicine of the United States of America (MEDLINE), Google Scholar and Physiotherapy Evidence Database (PEDro). The research included linking the following Health Science Descriptors in Portuguese: “chronic and neuropathic pain” and “cannabis” or “Cannabidiol” and “conventional treatment”. These descriptors were used in association with the Boolean logical operators “AND”. The searches resulted in 376 articles, of which 12 were used for the composition of the study. Results: It was evident that cannabis is an adjunctive treatment option, showing efficacy in the therapy of chronic and neuropathic pain. In addition, it works to improve conditions in patients with advanced cancer, which is of significant importance for the collection of evidence that allows the elaboration of some data on the dosage and formulation of cannabidiol specifically. Conclusion: Cannabis can be considered a strong adjunct in the treatment of chronic and neuropathic pain.

Author Biographies

Maria Helena Vieira Pereira Marques, Centro Universitário de Patos

Estudante de Medicina do Centro Universitário de Patos (UNIFIP).

Yan Carlos Gomes de Alencar, Centro Universitário de Patos

Estudante de Medicina do Centro Universitário de Patos (UNIFIP).

Déborah Alcântara Balduíno da Nóbrega, Centro Universitário de Patos

Estudante de Medicina do Centro Universitário de Patos (UNIFIP).

Fernando Wanderley Xavier, Centro Universitário de Patos

Estudante de Medicina do Centro Universitário de Patos (UNIFIP).

Lara Virgínia Lira Nogueira, Centro Universitário de Patos

Estudantes de Medicina do Centro Universitário de Patos (UNIFIP).

Milena Nunes Alves de Sousa, Centro Universitário de Patos (UNIFIP) e Faculdade São Francisco da Paraíba (FASP)

Enfermeira, Administradora e Turismóloga. Mestre em Ciências da Saúde. Doutorado e Pós-Doutorado em Promoção de Saúde. Pós-Doutora em Sistemas Agroindustriais pela Universidade Federal de Campina Grande (UFCG), Docente no Curso de Medicina do Centro Universitário de Patos (UNIFIP), Patos, Paraíba, Brasil.

References

ABRAMS, D. I. et al. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA network open. Chicago. v. 3, n. 7, p. 183-194, 2020. https://doi.org/10.1001/jamanetworkopen.2020.10874

ALMOG, S. et al. The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial. European journal of pain. Londres. v. 24, n.8, p. 1505–1516, 2020. https://doi.org/10.1002/ejp.1605

AMIN, M.R. et al. Pharmacology of Medical Cannabis. Adv Exp Med Biol. Nova York. v. 16, n. 3, p.1162:151-165, 2019. https://doi.org/10.1007/978-3-030-21737-2_8

AVIRAM, J. et al. Medical cannabis treatment for chronic pain: outcomes and prediction of response. European Journal of Pain. Londres. v. 25, n. 2, p. 359-374, 2021.

CHAVES, C. et al. Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pain medicine (Malden, Mass.). Londres. v. 21, n.10, p. 2212–2218, 2020. https://doi.org/10.1093/pm/pnaa303

DESCALZI, G. et al. Mecanismos epigenéticos da dor crônica. Trends Neuroscience. Londres. v. 38, n. 9. p. 237-246, 2015. https://doi.org/10.1016/j.tins.

GALVÃO T. F.; PANSANI T. S. A.; HARRAD, D. Principais itens para relatar Revisões sistemáticas e Meta-análises: a recomendação prisma. Epidemiologia e Serviços de Saúde. 2015.

GOOD, P. et al. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). BMC palliative care. Londres. v. 18, n. 1, p.110. 2019. https://doi.org/10.1186/s12904-019-0494-6

GÜL, Ş. K. et al. Duloxetina e pregabalina na dor neuropática de pacientes com câncer de pulmão. Comportamento do Cérebro. Istambul. v. 10, n. 3, p. 527, 2020. https://doi.org/10.1002/brb3.1527

HILL, K. P. et al. Cannabis e dor: uma revisão clínica. Cannabis and Cannabinoid Research. Califórnia. v. 2 , p. 96–104, 2017.

HUESTIS, M. A. et al. Caracterização da fase de absorção do fumo de cannabis. Farmacologia Clínica e Terapêutica. Rio de Janeiro. v. 52, n. 1 , p.31-41, 2017.

JADAD, A. R., et al. Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary? Controlled Clinical Trials. Nova York, v. 17, p. 1-12, 1996.

JO, E. et al. Medical Cannabis. Mayo Clin Proc. Filadélfia. v. 93, n. 12, p. 1842-1847, 2018. https://doi.org/10.1016/j.mayocp.2018.09.005

KREBS, E. E. et al. Efeito de medicamentos opióides versus não opióides na função relacionada à dor em pacientes com dor crônica nas costas ou dor na osteoartrite do quadril ou joelho: o ensaio clínico randomizado Space Jama. Chicago. v. 319, n. 9, p. 872-882. https://doi.org/10.1001/jama.2018.0899

LAGAS, I. F. et al. Are pain coping strategies and neuropathic pain associated with a worse outcome after conservative treatment for Achilles tendinopathy? A prospective cohort study. Journal of science and medicine in sport. Australia. v. 24, n. 9, p. 871–875, 2021. https://doi.org/10.1016/j.jsams.2021.04.001

LEE G. et al. Medical Cannabis for Neuropathic Pain. Current Pain Headache Reports. Nova York. v. 22, n.1, p. 8, 2018. https://doi.org/10.1007/s11916-018-0658-8

LIMEIRA, R. B. P.; NOGUEIRA, R. B. S. S.; SOUSA, M. N. A. O uso da cannabis sativa no tratamento da doença de alzheimer. Acadêmico mundo, v. 9, p. 1-15, 2021. Disponível em: https://drive.google.com/file/d/1JFjVgxCjVyNlLS2xYXX3-uWzLMtNjh8e/view. Acesso em: 10 jun. 2022.

LUCENA, L. R. T.; TIMÓTEO, P. A. D.; SOUSA, M. N. A. Avaliação do tratamento da fibromialgia: a terapia com canabinoides. Contemporânea - Revista de Ética e Filosofia Política, v. 2, p. 122-136, 2022.

MOREIRA, E. M. F.; SOUSA, M. N. A. Uso terapêutico da cannabis sativa para o tratamento de doenças. Journal of Medicine and Health Promotion, v. 6, p. 292-301, 2021.

NAFTALI, T. et al. Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial. PloS one. San Francisco. v. 16, n. 2, p.346, 2021. https://doi.org/10.1371/journal.pone.0246871

POLI, P. et al. Medical Cannabis in Patients with Chronic Pain: Effect on Pain Relief, Pain Disability, and Psychological aspects. A Prospective Non randomized Single Arm Clinical Trial. La Clinica terapêutica. Roma. v. 169, n.3, p.102–107, 2018. https://doi.org/10.7417/T.2018.2062

SARZI-PUTTINI, P. et al. Medical cannabis and cannabinoids in rheumatology: where are we now? Expert Rev Clin Immunol. Roma. v. 15, n. 10, p.1019-1032, 2019. https://doi.org/10.1080/1744666X.2019

SEE, M. et al. Dor crônica: uma revisão de sua epidemiologia e fatores associados em estudos de base populacional. British Journal of Anaesthesia. Londres. v. 123, n. 2, p. 273-283, 2019. https://doi.org/10.1016

SHARMA, N.; SRIVASTAV, A. K.; SAMUEL, A. J. Ensaio clínico randomizado: padrão ouro de desenhos experimentais-importância, vantagens, desvantagens e preconceitos. Revista Pesquisa em Fisioterapia. São Paulo. v. 3, p. 114, 2020.

VAN DE DONK, T. et al. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. Filadélfia. v. 160, n. 4, p. 860–86, 2019. https://doi.org/10.1097/j.pain.0000000000001464

WALLACE, M. S. et al. Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. The journal of pain. Londres. v. 16, n.7, p. 616-27, 2015. https://doi.org/110.1016/j.jpain.2015.03.008

WEIZMAN, L. et al. Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity. Neurology. Chicago. v. 91, n.14, p. 1285–1294, 2018. https://doi.org/10.1212/WNL.0000000000006293

WILSEY, B. et al. A cannabis vaporizada em baixa dose melhora significativamente a dor neuropática. Journal of Pain, v. 14, n. 2, p. 136-48, 2013. https://doi.org/10.1016/j.jpain.2012.10.009

Published

2022-06-30

How to Cite

Marques, M. H. V. P. ., Alencar, Y. C. G. de ., Nóbrega, D. A. B. da ., Xavier, F. W., Nogueira, L. V. L. ., & Sousa, M. N. A. de. (2022). PHYTOCANABIDIOIDS AS AN ADDITIVE TO THE TREATMENT OF ALGIC PROCESSES: A SYSTEMATIC REVIEW. Revista Brasileira De Filosofia E História, 11(1), 250–261. https://doi.org/10.18378/rbfh.v11i1.9546

Most read articles by the same author(s)

1 2 3 4 > >>